Skip to main content

Table 1 Demographic characteristics and prevalence of comorbidities included in the Charlson Comorbidity Index according to IHM due to major LEA in patients with T2DM in Spain, 2003-2013

From: Predictors of in-hospital mortality following major lower extremity amputations in type 2 diabetic patients using artificial neural networks

 

Prevalence

Condition IHM%

No condition IHM%

p-value

Men

26222

64.2

2363

9.0

  

<0.001

Women

14635

35.8

1715

11.7

   

<50 years

805

2.0

33

4.1

  

<0.001

50–64 years

6702

16.4

439

6.6

   

65–79 years

20334

49.8

1862

9.2

   

≥80 years

13016

31.9

1744

13.4

   

Myocardial infarction

2472

6.05

393

15.9

3685

9.6

<0.001

Congestive heart failure

4384

10.73

1020

23.3

3058

8.4

<0.001

Peripheral vascular disease

28120

68.83

2648

9.4

1430

11.2

<0.001

Cerebrovascular disease

3993

9.77

524

13.1

3554

9.6

<0.001

Dementia

2373

5.81

329

13.9

3749

9.7

<0.001

Chronic pulmonary disease

4706

11.52

570

12.1

3508

9.7

<0.001

Rheumatoid disease

523

1.28

51

9.8

4027

10.0

0.860

Peptic ulcer disease

375

0.92

56

14.9

4022

9.9

<0.001

Mild liver disease

1114

2.73

149

13.4

3929

9.9

<0.001

Hemiplegia or paraplegia

248

0.61

22

8.9

4056

10.0

0.559

Renal disease

7147

17.49

1054

14.7

3024

9.0

<0.001

Any malignancy

854

2.09

95

11.1

3983

10.0

0.260

Moderate or severe liver disease

202

0.49

48

23.8

4030

9.9

<0.001

Metastatic solid tumor

157

0.38

31

19.7

4047

9.9

<0.001

AIDS/HIV

27

0.07

2

7.4

4076

10.0

0.655

  1. P value comparing IHM between those with and without the condition. Any malignancy, including lymphoma and leukemia, except malignant neoplasm of skin